Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof

Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof

US Patent 11618778 · Granted Apr 4, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific chimeric antigen receptors targeting CD20 and BCMA2025
Combined chimeric antigen receptor targeting CD19 and CD20 and application there2025
Radio frequency parameter processing method and device, and mobile terminal and 2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune dis2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
Display panel and display device2025
Method for guaranteeing reliability of real-time scrambling and message transmis2025
T cell receptors recognizing MHC class II-restricted MAGE-A32025
Touch panel and display device2025
Charging control method and charging control apparatus2025
Peripheral component interconnect express device reset for autonomous driving sy2025